Content
All Posts > Content under Healthcare
Minerva Neurosciences Announces Pricing Of Public Offering Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Wednesday, June 28, 2017 8:53 PM EDT
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a price to the public of $7.75 per share.
In this article: NERV
Repligen Corporation Announces Proposed Public Offering Of Shares Of Common Stock
Article By:
NASDAQ GlobeNewswire
Read
Tuesday, June 27, 2017 10:02 PM EDT
Repligen Corporation today announced that it has commenced an underwritten public offering of $100,000,000 in shares of its common stock.
In this article: RGEN
5 Biomedical Stocks That Are Expected To Surge
Article By:
Zacks Investment Research
Read
Tuesday, June 27, 2017 5:01 PM EDT
Every investor struggles with balancing risk and reward when choosing their investments. Biomedical companies are known to offer large capital gains and growth prospects, yet they do not always come to fruition.
Is The Rite Aid / Walgreens Merger Really Going To Go Through?
Article By:
Small Cap Reporter
Read
Monday, June 26, 2017 5:01 PM EDT
The fact that this deal has taken so long and the threats of further suits continue to persist just make it that much more exciting.
Bankers, Bitcoins, Bubbles, And Breaking Bad
Video By:
Keith Schneider
Watch
Sunday, June 25, 2017 3:59 PM EDT
This past week, tech and biotech stocks led the market. The Healthcare sector roared with the prospect of higher profits, should Obamacare be shelved. IBB, the biotech ETF rallied 9.57%.
Markets Continue To Rally Despite Underlying Fears
Article By:
Tony Cherniawski
Read
Sunday, June 25, 2017 10:27 AM EDT
VIX continues to challenge both short and Intermediate term resistance before closing beneath them. A rally above long-term resistance at 12.60 implies that VIX may challenge its ending diagonal trendline at 17.50.
Top-Ranked Health Care ETFs To Buy Now
Article By:
Sweta Killa
Read
Saturday, June 24, 2017 2:39 PM EDT
The most popular healthcare ETF, XLV follows the Health Care Select Sector Index. This fund manages nearly $16.9 billion in its asset base and trades in heavy volume of around 7.9 million shares.
Week In Review: Shenzhen's BGI Plans $250 Million China IPO To Support Genomics Operations
Article By:
ChinaBio® Today
Read
Saturday, June 24, 2017 2:20 PM EDT
Known as a world leader in basic science sequencing, BGI now generates 55% of its income from clinical genomic tests, especially its NIFTY prenatal test for hereditary illnesses such as Down's Syndrome.
Bull In A China Bourse
Article By:
Vivian Lewis
Read
Saturday, June 24, 2017 2:16 PM EDT
It has become standard here in Britain to favor the FTSE 100 over broader UK indexes, because of its multinational company focus. Broader UK indexes depend on consumer spending which is down sharply.
In this article: AGU, ALV, BCS, CAE, CPA, CX, GSK, MXE, NOK, NVO, POT, SLB, SAN, DGRLY, DNACF, MXCHF, NPSNY, NTDOY, OROCF, RHHBY, SLFPY, TCTZF, INFY, SHPG, TEVA, RBGLY, FBASF, VRGDF
Johnson & Johnson: One Of The Best Dividend Aristocrats For Retirement Portfolios
Article By:
Simply Safe Dividends
Read
Saturday, June 24, 2017 1:58 PM EDT
Johnson & Johnson’s enormous scale allows it access to one of the industry’s largest R&D budgets, $9.1 billion in the past 12 months, or about 13% of revenue.
Biotechnology Stocks - Repligen Major Breakout
Article By:
Taki Tsaklanos
Read
Friday, June 23, 2017 5:10 PM EDT
The biotech index is still way below its all-time highs. However, Repligen managed to climb to its highs, which suggests a sector leader.
In this article: RGEN
Sector Showcase: Biotech Stocks Are The "Transformer" Michael Bay Should Be Watching
Article By:
Matt Weller
Read
Friday, June 23, 2017 2:45 PM EDT
The world's largest biotech fund, the iShares Nasdaq Biotech ETF (IBB), has had a quiet couple of months. For the last four months, the fund has been consolidating in a tight range between about 285.00 and 303.00.